Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: Breast Cancer Res Treat. 2020 Sep 13;185(1):1–12. doi: 10.1007/s10549-020-05917-7

Fig. 6.

Fig. 6

Clustering of necrosis volume or NVDCE (a) and necrosis-only volume as a percent of total tumor volume or %NVDCE (b), by dynamic contrast-enhanced MRI associated with response to neoadjuvant systemic therapy. There is no difference between TNBC patients with and without pathologic complete response (pCR)